Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, has entered into a strategic partnership with Shanghai, China-based China Pioneer Pharma Holdings Limited.
China Pioneer Pharma is an industry leader within China selling into more than 23,000 hospitals, with more than 1,000 dedicated sales representatives. China Pioneer Pharma recently underwent its initial public offering on the Hong Kong Stock Exchange and currently has a market capitalisation of over $700 million.
The prospect of entering the fast growing China orthopaedic implant market creates a large potential for expanded revenues, for both companies. “We are very excited to have the expertise of Pioneer behind us as we begin selling into the largest orthopaedic growth market in the world” said Rick Greiber, vice president of international sales and business development at Life Spine. “With a broad base of highly trained representatives and a strong management team, Pioneer is a great partner for Life Spine’s future growth in China.”